Dianthus Therapeutics
DNTH
DNTH
72 hedge funds and large institutions have $288M invested in Dianthus Therapeutics in 2019 Q3 according to their latest regulatory filings, with 8 funds opening new positions, 25 increasing their positions, 18 reducing their positions, and 6 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
more funds holding in top 10
Funds holding in top 10: →
0% less ownership
Funds ownership: 4.53% → 4.52% (-0%)
31% less capital invested
Capital invested by funds: $419M → $288M (-$131M)
Holders
72
Holding in Top 10
2
Calls
–
Puts
–
Top Buyers
| 1 | +$1.03M | |
| 2 | +$631K | |
| 3 | +$569K | |
| 4 |
Northern Trust
Chicago,
Illinois
|
+$534K |
| 5 |
CC
Casdin Capital
New York
|
+$462K |
Top Sellers
| 1 | -$5.54M | |
| 2 | -$1.54M | |
| 3 | -$498K | |
| 4 |
LCM
Laurion Capital Management
New York
|
-$485K |
| 5 |
AG
Artal Group
Luxembourg
|
-$347K |